Trademark Overview
On Monday, January 27, 2025, a trademark application was filed for HAEVN with the United States Patent and Trademark Office. The USPTO has given the HAEVN trademark a serial number of 99020239. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, August 6, 2025. This trademark is owned by Ionis Pharmaceuticals, Inc.. The HAEVN trademark is filed in the Education & Entertainment Services category with the following description:
Education and medical training services, namely, providing seminars, non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the field of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders; online journals, namely, blogs featuring information on hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders; providing a website featuring blogs and non-downloadable publications in the nature of articles, blogs, brochures, and guides in the fields of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, ...
